Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Finished Goods (2024 - 2025)

Historic Finished Goods for Legend Biotech (LEGN) over the last 2 years, with Q1 2025 value amounting to $2.8 million.

  • Legend Biotech's Finished Goods changed N/A to $2.8 million in Q1 2025 from the same period last year, while for Mar 2025 it was $2.8 million, marking a year-over-year change of. This contributed to the annual value of $2.0 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Legend Biotech reported Finished Goods of $2.8 million as of Q1 2025.
  • Over the past 5 years, Legend Biotech's Finished Goods peaked at $2.8 million during Q1 2025, and registered a low of $2.0 million during Q4 2024.